Visual Management for the Radiotherapy Process

Cancer Clinical Trial

— VMRTP  

Official title:

Visual Management for the Radiotherapy Process

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01854541
• Other study ID #: VMRTP
• Status: Completed
• Phase: N/A
• First received: May 13, 2013
• Last updated: April 9, 2015
• Start date: March 2013
• Est. completion date: January 2015

Study information

• Verified date: April 2015
• Source: Maastricht Radiation Oncology
• Contact: n/a
• Is FDA regulated: No
• Health authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The Visual Management for Radiotherapy Practice (VMRTP) aims to analyze, predict, visualize and shorten the waiting times for radiotherapy patients. The hypothesis is that this can be done by the introduction of models that can predict a patient being at risk for waiting too long as well as visual management tools that visualize the radiotherapy process.

Description:

In a retrospective cohort of radiotherapy patients, time stamps of various steps in the radiotherapy process (diagnosis, multi-disciplinary board, referral, intake, simulation, treatment planning, quality control, first fraction of radiotherapy) will be collected. These will be combined with patient, tumor and patient-process (e.g. referring physician, treating physician, busy-at-the-time, referring hospital) related features. Based on these a predictive model will be learned that can estimate the probability at various stages of the process that the patient waits too long. Visual management will be developed that can visualize the predicted waiting time.

Process interventions aimed at reducing waiting times will be tested prospectively.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10000
• Est. completion date: January 2015
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

Patients receiving radiotherapy

Exclusion Criteria:

Patients not receiving radiotherapy

Study Design

Observational Model: Cohort

Related Conditions & MeSH terms

• Cancer

Locations

Country	Name	City	State
Netherlands	MAASTRO clinic	Maastricht

Sponsors (2)

Lead Sponsor	Collaborator
Maastricht Radiation Oncology	Maastro Clinic, The Netherlands

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	referral and first day of radiotherapy	Waiting time between referral and first day of radiotherapy	3 months	No
Secondary	Diagnosis and first day of radiotherapy	Waiting time between diagnosis and first day of radiotherapy	3 months	No
Secondary	multi-disciplinary board and first day of radiotherapy	Waiting time between multi-disciplinary board and first day of radiotherapy	3 months	No
Secondary	intake and first day of radiotherapy	Waiting time between intake and first day of radiotherapy	3 months	No
Secondary	simulation and first day of radiotherapy	Waiting time between simulation and first day of radiotherapy	3 months	No